BACTILOC-CV
MRP: 3,735
Packaging: 10x10
Pack Type: tablet
Composition:
Cefpodoxime 200mg + Clavulanic Acid 125
Indication:
Upper & Lower RTI, Otitis Media, Urinary Tract Infections, Gonorrhea, Skin & Soft Tissue Infections, Acute Maxillary sinusitis.
Description:
Cefpodoxime 50mg + Clavulanic Acid 31.125mg DT is a pediatric antibiotic formulation that combines a third-generation cephalosporin (Cefpodoxime) with a beta-lactamase inhibitor (Clavulanic Acid) to provide broad-spectrum protection against bacterial infections. This combination enhances the antibacterial activity by preventing resistance caused by beta-lactamase-producing organisms.
It is especially useful in treating respiratory tract infections, ENT infections, urinary tract infections, skin infections, and soft tissue infections in children. The dispersible tablet format ensures ease of administration for pediatric patients who struggle with swallowing tablets.
Tags:
- Broad-spectrum antibacterial action
- Effective against beta-lactamase-producing bacteria
- Dispersible format ideal for pediatric use
- Helps treat resistant ENT, respiratory, and urinary infections
- Well-tolerated with improved compliance in children
Usage Information
Dosage
Children (as prescribed by a pediatrician): Usual dosage is based on weight, often 10–15 mg/kg/day of Cefpodoxime component in divided doses. Administration: Disperse one tablet in water and give with food. Complete the full course, even if symptoms improve early.
Side Effects
Diarrhea Nausea Abdominal pain Rash or skin allergy Vomiting Headache Rare: Allergic reactions or elevated liver enzymes
Contraindications
Known hypersensitivity to cephalosporins, penicillins, or beta-lactam antibiotics Severe renal or hepatic impairment (dose adjustment may be needed) History of antibiotic-associated colitis Avoid in children with known GI disorders unless prescribed